The world's largest biotech drugmaker posted revenue of $6.21 billion in the period, which also topped Street forecasts. Nine analysts surveyed by ...
News
- Amgen: 2Q Earnings Snapshot
- Financings for July 28, 2020
San Antonio-based Bioaffinity Technologies, a privately held biotech company, said it has closed a nonbrokered, secured convertible note financing ...
- Texas A&M biotech facility tapped to manufacture potential COVID-19 vaccine
A Texas biotech facility in College Station could soon take the lead in producing a COVID-19 vaccine next year, if Novavax Inc. proves successful in ...
- bioAffinity Technologies Announces Closing of $5000000 Convertible Note Financing
SAN ANTONIO--(BUSINESS WIRE)--bioAffinity Technologies, a privately held biotech company, today announced it has closed a non-brokered, ...
- 'This is something we need,' COVID-19 vaccine trial to start in San Antonio
Biotech company, Moderna, is in a hurry to come up with a vaccine that will help make antibodies to fight COVID-19. Doctor Douglas Denham, Chief ...